Revelation Biosciences, Inc. (REVB) stock
REVBNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as REVBW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$3.85−0.03 (-0.77%)
Close on Nov 18, 2026Market cap $15.34MP/E –Yield –
Revelation Biosciences price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Revelation Biosciences's price to book ratio was 1.7× on Nov 11, 2026, against 8.7× a year earlier. Over the last 2 years it ranged from 0.2× to 447.1×, with a median of 7.0×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.7× | −5.6 |
| 2025 | Dec 31, 2025 | 7.3× | −375.0 |
| 2024 | Jul 31, 2024 | 382.3× | – |
See a number that looks wrong?